Remus Pharmaceuticals Ltd Annually Results

Gross Sales

620.36

212.94

Excise Duty

0

0

Net Sales

620.36

212.94

Other Operating Income

0

0

Other Income

4.98

2.83

Total Income

625.34

215.77

Total Expenditure

574.67

183.98

PBIDT

50.67

31.79

Interest

1.46

0.5

PBDT

49.21

31.29

Depreciation

1.87

1.12

Minority Interest Before NP

0

0

Tax

8.85

6.57

Deferred Tax

0.07

-0.68

Reported Profit After Tax

38.42

24.28

Minority Interest After NP

9.35

3.76

Net Profit after Minority Interest

29.07

20.52

Extra-ordinary Items

0

0

Adjusted Profit After Extra-ordinary item

29.07

20.52

EPS (Unit Curr.)

65.21

42.97

Book Value (Unit Curr.)

0

0

Dividend (%)

0

0

Equity

5.89

1.47

Public Shareholding (Number)

0

0

Public Shareholding (%)

0

0

Pledged/Encumbered - No. of Shares

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

Pledged/Encumbered - % in Total Equity

0

0

Non Encumbered - No. of Shares

0

0

Non Encumbered - % in Total Promoters Holding

0

0

Non Encumbered - % in Total Equity

0

0

PBIDTM(%)

8.16

14.92

PBDTM(%)

7.93

14.69

PATM(%)

6.19

11.4